## **Core Concept**
The management of hypertension in pregnancy is crucial to prevent complications for both the mother and the fetus. The choice of antihypertensive medication is guided by its safety profile for both the mother and the fetus, as well as its efficacy in controlling blood pressure.

## **Why the Correct Answer is Right**
Methyldopa (Option D) is commonly used in the management of hypertension during pregnancy. It works by stimulating α2-adrenergic receptors in the brain, which decreases the sympathetic tone and subsequently lowers blood pressure. Methyldopa has a long history of safe use in pregnancy and is often considered a first-line agent due to its favorable safety profile for both the mother and the fetus.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Nifedipine, a calcium channel blocker, can be used in pregnancy but is usually considered after methyldopa or labetalol, especially in urgent situations. It's not typically the first choice for chronic hypertension management in pregnancy.
- **Option B:** Propranolol, a beta-blocker, can be used in pregnancy but with caution, particularly in the first and third trimesters. It's not usually the first line due to potential growth restriction effects on the fetus.
- **Option C:** Lisinopril, an ACE inhibitor, is contraindicated in pregnancy due to the risk of fetal renal damage and other complications. ACE inhibitors are known to be harmful to the fetus.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in pregnancy, the goal is to control hypertension while ensuring the safety of both the mother and the fetus. Methyldopa is often a preferred agent for long-term management due to its safety profile. However, the choice of antihypertensive agent may vary depending on specific clinical scenarios and comorbid conditions.

## **Correct Answer:** D. Methyldopa.